Annual Net Income
-$46.51 M
-$39.17 M-534.06%
01 December 2023
Summary:
Perspective Therapeutics annual net profit is currently -$46.51 million, with the most recent change of -$39.17 million (-534.06%) on 01 December 2023. During the last 3 years, it has fallen by -$43.12 million (-1273.13%). CATX annual net income is now -116.95% below its all-time high of $274.37 million, reached on 01 June 2005.CATX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$15.12 M
-$3.42 M-29.20%
01 September 2024
Summary:
Perspective Therapeutics quarterly net profit is currently -$15.12 million, with the most recent change of -$3.42 million (-29.20%) on 01 September 2024. Over the past year, it has increased by +$9.55 million (+38.72%). CATX quarterly net income is now -913.23% below its all-time high of $1.86 million, reached on 01 December 1998.CATX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$63.78 M
-$4.77 M-8.08%
01 September 2024
Summary:
Perspective Therapeutics TTM net profit is currently -$63.78 million, with the most recent change of -$4.77 million (-8.08%) on 01 September 2024. Over the past year, it has dropped by -$17.28 million (-37.15%). CATX TTM net income is now -1839.20% below its all-time high of $3.67 million, reached on 01 September 1999.CATX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +38.7% | -37.1% |
| 3 y3 years | -1273.1% | -842.8% | -1028.3% |
| 5 y5 years | -804.1% | -1585.8% | -1521.0% |
CATX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1273.1% | at low | -3976.0% | +38.7% | -1028.3% | at low |
| 5 y | 5 years | -1273.1% | at low | -3976.0% | +38.7% | -1824.7% | at low |
| alltime | all time | -117.0% | at low | -913.2% | +38.7% | -1839.2% | at low |
Perspective Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.12 M(+29.2%) | -$63.78 M(+8.1%) |
| June 2024 | - | -$11.70 M(-4.7%) | -$59.02 M(+1.0%) |
| Mar 2024 | - | -$12.28 M(-50.2%) | -$58.42 M(+25.6%) |
| Dec 2023 | -$46.51 M(+534.1%) | -$24.68 M(+138.3%) | -$46.51 M(+113.0%) |
| Sept 2023 | - | -$10.36 M(-6.8%) | -$21.83 M(+40.5%) |
| June 2023 | - | -$11.11 M(+2893.5%) | -$15.54 M(+138.5%) |
| Mar 2023 | - | -$371.00 K(-90.9%) | -$6.52 M(-28.4%) |
| Dec 2022 | -$7.33 M(+0.9%) | - | - |
| Sept 2022 | - | -$4.07 M(+95.8%) | -$9.10 M(+25.1%) |
| June 2022 | - | -$2.08 M(+54.3%) | -$7.27 M(+16.3%) |
| June 2022 | -$7.27 M(+114.7%) | - | - |
| Mar 2022 | - | -$1.35 M(-16.0%) | -$6.25 M(+10.6%) |
| Dec 2021 | - | -$1.60 M(-28.5%) | -$5.65 M(+15.0%) |
| Sept 2021 | - | -$2.24 M(+111.4%) | -$4.92 M(+45.2%) |
| June 2021 | -$3.39 M(-1.7%) | - | - |
| June 2021 | - | -$1.06 M(+42.4%) | -$3.39 M(-3.6%) |
| Mar 2021 | - | -$745.00 K(-14.2%) | -$3.51 M(+6.0%) |
| Dec 2020 | - | -$868.00 K(+21.7%) | -$3.31 M(-0.9%) |
| Sept 2020 | - | -$713.00 K(-40.0%) | -$3.34 M(-3.0%) |
| June 2020 | -$3.45 M(-33.0%) | -$1.19 M(+118.0%) | -$3.45 M(+2.8%) |
| Mar 2020 | - | -$545.00 K(-39.2%) | -$3.35 M(-14.8%) |
| Dec 2019 | - | -$897.00 K(+9.9%) | -$3.94 M(-11.6%) |
| Sept 2019 | - | -$816.00 K(-25.5%) | -$4.45 M(-13.5%) |
| June 2019 | -$5.14 M(-23.2%) | -$1.09 M(-2.8%) | -$5.14 M(-19.7%) |
| Mar 2019 | - | -$1.13 M(-20.3%) | -$6.41 M(-3.1%) |
| Dec 2018 | - | -$1.41 M(-6.2%) | -$6.61 M(-0.7%) |
| Sept 2018 | - | -$1.51 M(-36.0%) | -$6.66 M(-0.6%) |
| June 2018 | -$6.70 M(+8.7%) | -$2.36 M(+77.0%) | -$6.70 M(+8.1%) |
| Mar 2018 | - | -$1.33 M(-9.0%) | -$6.20 M(-0.4%) |
| Dec 2017 | - | -$1.46 M(-5.4%) | -$6.22 M(+0.2%) |
| Sept 2017 | - | -$1.55 M(-16.7%) | -$6.21 M(+0.8%) |
| June 2017 | -$6.16 M(+30.8%) | -$1.85 M(+36.4%) | -$6.16 M(+12.2%) |
| Mar 2017 | - | -$1.36 M(-6.2%) | -$5.49 M(+3.1%) |
| Dec 2016 | - | -$1.45 M(-3.2%) | -$5.33 M(+2.7%) |
| Sept 2016 | - | -$1.50 M(+26.4%) | -$5.19 M(+10.1%) |
| June 2016 | -$4.71 M(+28.0%) | -$1.19 M(-0.8%) | -$4.71 M(+3.3%) |
| Mar 2016 | - | -$1.20 M(-8.8%) | -$4.56 M(+5.6%) |
| Dec 2015 | - | -$1.31 M(+28.5%) | -$4.32 M(+10.3%) |
| Sept 2015 | - | -$1.02 M(-1.4%) | -$3.92 M(+6.4%) |
| June 2015 | -$3.68 M(-38.2%) | -$1.03 M(+8.5%) | -$3.68 M(-14.9%) |
| Mar 2015 | - | -$953.60 K(+5.1%) | -$4.32 M(-20.7%) |
| Dec 2014 | - | -$907.00 K(+15.4%) | -$5.45 M(-0.4%) |
| Sept 2014 | - | -$785.90 K(-53.2%) | -$5.47 M(-8.1%) |
| June 2014 | -$5.96 M(+54.5%) | -$1.68 M(-19.5%) | -$5.96 M(+13.0%) |
| Mar 2014 | - | -$2.08 M(+124.7%) | -$5.27 M(+35.0%) |
| Dec 2013 | - | -$927.00 K(-27.1%) | -$3.91 M(-5.5%) |
| Sept 2013 | - | -$1.27 M(+27.9%) | -$4.13 M(+7.2%) |
| June 2013 | -$3.86 M(+10.5%) | -$993.60 K(+39.0%) | -$3.86 M(-5.2%) |
| Mar 2013 | - | -$715.00 K(-38.1%) | -$4.07 M(+4.2%) |
| Dec 2012 | - | -$1.15 M(+16.2%) | -$3.91 M(+15.5%) |
| Sept 2012 | - | -$993.70 K(-17.5%) | -$3.38 M(-3.1%) |
| June 2012 | -$3.49 M(+22.8%) | -$1.21 M(+117.9%) | -$3.49 M(+16.5%) |
| Mar 2012 | - | -$552.90 K(-12.1%) | -$3.00 M(-13.7%) |
| Dec 2011 | - | -$628.70 K(-43.0%) | -$3.47 M(+13.0%) |
| Sept 2011 | - | -$1.10 M(+54.8%) | -$3.07 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | -$2.84 M(-29.5%) | -$712.00 K(-30.9%) | -$2.84 M(-11.5%) |
| Mar 2011 | - | -$1.03 M(+351.7%) | -$3.21 M(-2.0%) |
| Dec 2010 | - | -$228.10 K(-73.8%) | -$3.28 M(-18.0%) |
| Sept 2010 | - | -$871.90 K(-19.4%) | -$4.00 M(-0.9%) |
| June 2010 | -$4.03 M(-34.5%) | -$1.08 M(-1.2%) | -$4.03 M(-4.1%) |
| Mar 2010 | - | -$1.10 M(+15.3%) | -$4.21 M(-8.4%) |
| Dec 2009 | - | -$949.90 K(+4.8%) | -$4.59 M(-13.0%) |
| Sept 2009 | - | -$906.70 K(-27.7%) | -$5.27 M(-14.4%) |
| June 2009 | -$6.16 M(-28.0%) | -$1.25 M(-15.3%) | -$6.16 M(-3.0%) |
| Mar 2009 | - | -$1.48 M(-9.4%) | -$6.35 M(-9.8%) |
| Dec 2008 | - | -$1.63 M(-8.9%) | -$7.04 M(-14.1%) |
| Sept 2008 | - | -$1.79 M(+24.4%) | -$8.19 M(-4.3%) |
| June 2008 | -$8.56 M(-10.9%) | -$1.44 M(-33.6%) | -$8.56 M(-13.1%) |
| Mar 2008 | - | -$2.17 M(-22.1%) | -$9.85 M(+1.5%) |
| Dec 2007 | - | -$2.79 M(+29.0%) | -$9.71 M(+9.8%) |
| Sept 2007 | - | -$2.16 M(-21.1%) | -$8.84 M(-8.0%) |
| June 2007 | -$9.61 M(+16.9%) | -$2.74 M(+35.1%) | -$9.61 M(+1.2%) |
| Mar 2007 | - | -$2.02 M(+5.5%) | -$9.49 M(+4.0%) |
| Dec 2006 | - | -$1.92 M(-34.5%) | -$9.13 M(-0.7%) |
| Sept 2006 | - | -$2.93 M(+11.8%) | -$9.19 M(+11.8%) |
| June 2006 | -$8.22 M(-103.0%) | -$2.62 M(+57.8%) | -$8.22 M(+46.8%) |
| Mar 2006 | - | -$1.66 M(-16.1%) | -$5.60 M(+53.9%) |
| Dec 2005 | - | -$1.98 M(+1.0%) | -$3.64 M(+118.9%) |
| Sept 2005 | - | -$1.96 M(-748.9%) | -$1.66 M(-650.6%) |
| June 2005 | $274.37 M(>+9900.0%) | - | - |
| Mar 2005 | - | $302.00 K(-8488.9%) | $301.70 K(<-9900.0%) |
| Dec 2004 | - | -$3600.00(-14.3%) | -$1900.00(-102.5%) |
| Sept 2004 | $75.80 K(-226.3%) | -$4200.00(-156.0%) | $75.70 K(+8.3%) |
| June 2004 | - | $7500.00(-568.8%) | $69.90 K(+43.8%) |
| Mar 2004 | - | -$1600.00(-102.2%) | $48.60 K(+40.9%) |
| Dec 2003 | - | $74.00 K(-840.0%) | $34.50 K(-157.5%) |
| Sept 2003 | -$60.00 K(+1.5%) | -$10.00 K(-27.5%) | -$60.00 K(-4.2%) |
| June 2003 | - | -$13.80 K(-12.1%) | -$62.60 K(-0.9%) |
| Mar 2003 | - | -$15.70 K(-23.4%) | -$63.20 K(-3.2%) |
| Dec 2002 | - | -$20.50 K(+62.7%) | -$65.30 K(+10.3%) |
| Sept 2002 | -$59.10 K(-125.1%) | -$12.60 K(-12.5%) | -$59.20 K(-124.6%) |
| June 2002 | - | -$14.40 K(-19.1%) | $241.00 K(+4.0%) |
| Mar 2002 | - | -$17.80 K(+23.6%) | $231.70 K(-1.7%) |
| Dec 2001 | - | -$14.40 K(-105.0%) | $235.70 K(+0.2%) |
| Sept 2001 | $235.10 K(-458.4%) | $287.60 K(-1313.5%) | $235.20 K(-396.2%) |
| June 2001 | - | -$23.70 K(+71.7%) | -$79.40 K(+15.7%) |
| Mar 2001 | - | -$13.80 K(-7.4%) | -$68.60 K(+1.3%) |
| Dec 2000 | - | -$14.90 K(-44.8%) | -$67.70 K(+3.0%) |
| Sept 2000 | -$65.60 K(-103.6%) | -$27.00 K(+109.3%) | -$65.70 K(-103.7%) |
| June 2000 | - | -$12.90 K(0.0%) | $1.80 M(+0.2%) |
| Mar 2000 | - | -$12.90 K(0.0%) | $1.80 M(+0.1%) |
| Dec 1999 | - | -$12.90 K(-100.7%) | $1.80 M(-51.1%) |
| Sept 1999 | $1.82 M(-1407.9%) | $1.84 M(<-9900.0%) | $3.67 M(+100.5%) |
| June 1999 | - | -$15.70 K(+8.3%) | $1.83 M(-0.9%) |
| Mar 1999 | - | -$14.50 K(-100.8%) | $1.84 M(-0.8%) |
| Dec 1998 | - | $1.86 M | $1.86 M |
| Sept 1998 | -$139.50 K(-67.3%) | - | - |
| Sept 1997 | -$426.10 K(-80.2%) | - | - |
| Sept 1996 | -$2.15 M(+129.1%) | - | - |
| Sept 1995 | -$939.20 K(+114.6%) | - | - |
| Sept 1994 | -$437.60 K | - | - |
FAQ
- What is Perspective Therapeutics annual net profit?
- What is the all time high annual net income for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly net income year-on-year change?
- What is Perspective Therapeutics TTM net profit?
- What is the all time high TTM net income for Perspective Therapeutics?
- What is Perspective Therapeutics TTM net income year-on-year change?
What is Perspective Therapeutics annual net profit?
The current annual net income of CATX is -$46.51 M
What is the all time high annual net income for Perspective Therapeutics?
Perspective Therapeutics all-time high annual net profit is $274.37 M
What is Perspective Therapeutics quarterly net profit?
The current quarterly net income of CATX is -$15.12 M
What is the all time high quarterly net income for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly net profit is $1.86 M
What is Perspective Therapeutics quarterly net income year-on-year change?
Over the past year, CATX quarterly net profit has changed by +$9.55 M (+38.72%)
What is Perspective Therapeutics TTM net profit?
The current TTM net income of CATX is -$63.78 M
What is the all time high TTM net income for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM net profit is $3.67 M
What is Perspective Therapeutics TTM net income year-on-year change?
Over the past year, CATX TTM net profit has changed by -$17.28 M (-37.15%)